The results of the present study show that propofol inhibits oxidative stress and DMT1 expression and eventually downregulates GSH and ROS production, which disrupts the energy supply required for tumor growth and metabolism (Figure 7). This evidence concerns the gene SLC11A2 and neoplasm.